BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 33463901)

  • 1. Stress hyperglycemia, cardiac glucotoxicity, and critically ill patient outcomes current clinical and pathophysiological evidence.
    Scheen M; Giraud R; Bendjelid K
    Physiol Rep; 2021 Jan; 9(2):e14713. PubMed ID: 33463901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Glycaemia control in critically ill patients is justified and effective].
    Rybka J
    Vnitr Lek; 2010 Sep; 56(9 Suppl):977-87. PubMed ID: 21137171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose control in the intensive care unit.
    Fahy BG; Sheehy AM; Coursin DB
    Crit Care Med; 2009 May; 37(5):1769-76. PubMed ID: 19325461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feeding the critically ill obese patient: a systematic review protocol.
    Secombe P; Harley S; Chapman M; Aromataris E
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):95-109. PubMed ID: 26571286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenous glucose administration impairs glucose tolerance and pancreatic insulin secretion during acute sepsis in non-diabetic mice.
    Watanabe Y; Singamsetty S; Zou B; Guo L; Stefanovski D; Alonso LC; Garcia-Ocana A; O'Donnell CP; McVerry BJ
    PLoS One; 2013; 8(6):e67716. PubMed ID: 23826335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sepsis hyperglycemia in the ICU: from the mechanism to the clinic].
    Aleman L; Guerrero J
    Rev Med Chil; 2018 Apr; 146(4):502-510. PubMed ID: 29999126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stress-hyperglycemia, insulin and immunomodulation in sepsis.
    Marik PE; Raghavan M
    Intensive Care Med; 2004 May; 30(5):748-56. PubMed ID: 14991101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypocaloric support in the critically ill.
    Patiño JF; de Pimiento SE; Vergara A; Savino P; Rodríguez M; Escallón J
    World J Surg; 1999 Jun; 23(6):553-9. PubMed ID: 10227923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic AT1 blockade improves glucose homeostasis in obese OLETF rats.
    Rodriguez R; Minas JN; Vazquez-Medina JP; Nakano D; Parkes DG; Nishiyama A; Ortiz RM
    J Endocrinol; 2018 Jun; 237(3):271-284. PubMed ID: 29643115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Insulin resistance and protein catabolism in critically ill patients].
    Bierbrauer J; Weber-Carstens S
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2011 Apr; 46(4):268-74; quiz 275. PubMed ID: 21484622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alterations of blood glucose homeostasis during septic or injury stress--hyperglycemia].
    Buczkowska EO
    Wiad Lek; 2002; 55(11-12):731-44. PubMed ID: 12715356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic control.
    Robinson LE; van Soeren MH
    AACN Clin Issues; 2004; 15(1):45-62. PubMed ID: 14767364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease.
    Mota M; Banini BA; Cazanave SC; Sanyal AJ
    Metabolism; 2016 Aug; 65(8):1049-61. PubMed ID: 26997538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiological aspects of hyperglycemia in children with meningococcal sepsis and septic shock: a prospective, observational cohort study.
    Verhoeven JJ; den Brinker M; Hokken-Koelega AC; Hazelzet JA; Joosten KF
    Crit Care; 2011; 15(1):R44. PubMed ID: 21276273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Damaging effects of hyperglycemia on cardiovascular function: spotlight on glucose metabolic pathways.
    Mapanga RF; Essop MF
    Am J Physiol Heart Circ Physiol; 2016 Jan; 310(2):H153-73. PubMed ID: 26519027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of oxidative stress and metabolic homeostasis by the suppression of postprandial hyperglycemia.
    Takeda E; Arai H; Yamamoto H; Okumura H; Taketani Y
    J Med Invest; 2005 Nov; 52 Suppl():259-65. PubMed ID: 16366512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Transient Metabolic Recovery from Early Life Glucose Intolerance in Cystic Fibrosis Ferrets Occurs During Pancreatic Remodeling.
    Yi Y; Sun X; Gibson-Corley K; Xie W; Liang B; He N; Tyler SR; Uc A; Philipson LH; Wang K; Hara M; Ode KL; Norris AW; Engelhardt JF
    Endocrinology; 2016 May; 157(5):1852-65. PubMed ID: 26862997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin prevents pancreatic β-cell loss due to glucotoxicity: the relationship between oxidative stress and endoplasmic reticulum stress.
    Park JH; Shim HM; Na AY; Bae KC; Bae JH; Im SS; Cho HC; Song DK
    J Pineal Res; 2014 Mar; 56(2):143-53. PubMed ID: 24168371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bench-to-bedside review: Glucose and stress conditions in the intensive care unit.
    Losser MR; Damoisel C; Payen D
    Crit Care; 2010; 14(4):231. PubMed ID: 20727232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild Physiologic Hyperglycemia Induces Hepatic Insulin Resistance in Healthy Normal Glucose-Tolerant Participants.
    Tripathy D; Merovci A; Basu R; Abdul-Ghani M; DeFronzo RA
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2842-2850. PubMed ID: 30789980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.